Does enoxaparin 40 mg subcutaneously per day reduce the risk of venous thromboembolism in patients with acute medical illnesses compared to placebo?
Enoxaparin 40 mg daily is safe and effective for VTE prophylaxis in acutely ill medical patients.
Prophylactic treatment with 40 mg of enoxaparin subcutaneously per day safely and effectively reduces the risk of venous thromboembolism in patients with acute medical illnesses.
Samama et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: